Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database
- PMID: 10401733
- DOI: 10.1016/s1072-7515(99)00075-7
Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database
Abstract
Background: The National Cancer Database is an electronic registry system sponsored jointly by the American College of Surgeons Commission on Cancer and the American Cancer Society. Patients diagnosed with pancreatic adenocarcinoma from 1985 to 1995 were analyzed for trends in stage of disease, treatment patterns, and outcomes.
Study design: Seven annual requests for data were issued by the National Cancer Database from 1989 through 1995. Data on 100,313 patients were voluntarily submitted using a standardized reporting format.
Results: The anatomic site distribution was: head, 78%; body, 11%; and tail, 11%. The ratios of limited to advanced disease (Stage I/Stage IV) were 0.70 for tumors in the head, 0.24 for body tumors, and 0.10 for tail tumors. Of all patients, 83% did not have a surgical procedure and 58% did not have cancer-directed treatment. Resection was done for 9,044 (9%) patients, including 22% of those with Stage I disease. The overall 5-year survival rate was 23.4% for patients who had pancreatectomy, compared with 5.2% for those who had no cancer-directed treatment.
Conclusions: Overall survival rates for pancreatic cancer have not changed in 2 decades. A small minority of patients presented with limited, resectable disease, but the best survival rates per stage were achieved after surgical resection. Five-year survival rates after resection reported herein corroborated the improved survival rates of more recent large, single institution studies.
Comment in
-
Pancreatic cancer: "true, false, or just a start?".J Am Coll Surg. 1999 Jul;189(1):129-30. doi: 10.1016/s1072-7515(99)00081-2. J Am Coll Surg. 1999. PMID: 10401749 No abstract available.
Similar articles
-
Treatment patterns and outcomes for pancreatic tumors in children: an analysis of the National Cancer Database.Pediatr Surg Int. 2020 Mar;36(3):357-363. doi: 10.1007/s00383-020-04617-z. Epub 2020 Jan 27. Pediatr Surg Int. 2020. PMID: 31989243
-
The National Cancer Data Base report on pancreatic cancer.Cancer. 1995 Nov 1;76(9):1671-7. doi: 10.1002/1097-0142(19951101)76:9<1671::aid-cncr2820760926>3.0.co;2-r. Cancer. 1995. PMID: 8635074
-
Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium.Ann Surg Oncol. 2018 Nov;25(12):3492-3501. doi: 10.1245/s10434-018-6705-1. Epub 2018 Aug 27. Ann Surg Oncol. 2018. PMID: 30151560
-
[Trend in the management of pancreatic adenocarcinoma--Japan vs. US and Europe].Nihon Geka Gakkai Zasshi. 2006 Jul;107(4):187-91. Nihon Geka Gakkai Zasshi. 2006. PMID: 16878412 Review. Japanese.
-
Multimodality management of borderline resectable pancreatic adenocarcinoma.Chin Clin Oncol. 2017 Jun;6(3):27. doi: 10.21037/cco.2017.06.17. Chin Clin Oncol. 2017. PMID: 28705004 Review.
Cited by
-
Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer.Oncol Lett. 2016 May;11(5):3441-3445. doi: 10.3892/ol.2016.4381. Epub 2016 Mar 29. Oncol Lett. 2016. PMID: 27123132 Free PMC article.
-
Entry effects of droplet in a micro confinement: Implications for deformation-based circulating tumor cell microfiltration.Biomicrofluidics. 2015 Mar 31;9(2):024108. doi: 10.1063/1.4916645. eCollection 2015 Mar. Biomicrofluidics. 2015. PMID: 25945134 Free PMC article.
-
Detection of pancreatic cancer using serum protein profiling.HPB (Oxford). 2013 Aug;15(8):602-10. doi: 10.1111/hpb.12017. Epub 2012 Nov 30. HPB (Oxford). 2013. PMID: 23458426 Free PMC article.
-
Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy.Small GTPases. 2011 Sep;2(5):264-267. doi: 10.4161/sgtp.2.5.17367. Epub 2011 Sep 1. Small GTPases. 2011. PMID: 22292129 Free PMC article.
-
Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.World J Surg. 2023 Mar;47(3):729-739. doi: 10.1007/s00268-022-06818-0. Epub 2022 Nov 10. World J Surg. 2023. PMID: 36357802 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical